论文部分内容阅读
一上市药讯1抗癌药Zeneca公司的芳香酶抑制剂anastrozole（Arimidex）已在英国首次上市，用于治疗绝经后妇女的进行性乳腺癌。本品对两个芳香酶具有高度选择性，能影响非卵巢的雌激素合成，与其它同类产品相比副作用小，降低雌激素水平的活力强。大约有2／3的乳腺瘤是雌激素依?
A listing of drug information 1 anticancer drug Zeneca’s aromatase inhibitor anastrozole (Arimidex) has been first listed in the UK for the treatment of progressive breast cancer in postmenopausal women. This product is highly selective for both aromatase enzymes and can affect the synthesis of estrogen in non-ovarian tissues. Compared with other similar products, this product has low side effects and low estrogen levels. About two-thirds of breast tumors are estrogen-dependent?